NUCALA 100 MG/ML SOL INJ CT CAR VD TRANS + CAN APLIC + AGU
Apresentação · Câmara de Regulação do Mercado de Medicamentos (CMED), Secretaria Executiva exercida pela Agência Nacional de Vigilância Sanitária (ANVISA) · Brasil
-
Número de registro
1010703350032 -
GGREM
510620110056207 -
Código de barras
7896015592004
O que a fonte publica
- Detentor do registro
- GLAXOSMITHKLINE BRASIL LTDA
- Princípios ativos
- MEPOLIZUMABE
- Embalagem
- 100 MG/ML SOL INJ CT CAR VD TRANS + CAN APLIC + AGU
- Regime de dispensação
- Tarja Vermelha
- Tipo de produto
- Biológico
- Classe terapêutica
- R3M - ANTIASMÁTICOS INIBIDORES DA INTERLEUCINA
- Prescrição
- Sob prescrição ou restrito
Nomes pelos quais este registro é encontrado
Dados completos da fonte
{
"name": "NUCALA 100 MG/ML SOL INJ CT CAR VD TRANS + CAN APLIC + AGU",
"holder": "GLAXOSMITHKLINE BRASIL LTDA",
"stripe": "Tarja Vermelha",
"barcodes": [
"7896015592004"
],
"confaz87": false,
"currency": "BRL",
"marketed": null,
"ggremCode": "510620110056207",
"useDomain": "unknown",
"capApplies": null,
"icmsExempt": false,
"holderTaxId": "33.247.743/0001-10",
"priceRegime": "Regulado",
"productName": "NUCALA",
"productType": "Biológico",
"hospitalOnly": false,
"presentation": "100 MG/ML SOL INJ CT CAR VD TRANS + CAN APLIC + AGU",
"sourceStatus": null,
"supplyRegime": "Tarja Vermelha",
"factoryPrices": {
"icms-0": "8469.18",
"icms-12": "9624.07",
"icms-17": "10203.83",
"icms-18": "10328.27",
"icms-19": "10455.78",
"icms-20": "10586.48",
"icms-21": "10720.48",
"icms-22": "10857.92",
"icms-23": "10998.93",
"icms-17.5": "10265.67",
"icms-19.5": "10520.72",
"icms-20.5": "10653.06",
"icms-22.5": "10927.98",
"icms-12-alc": "8592.92",
"icms-17-alc": "9110.56",
"icms-18-alc": "9221.67",
"icms-19-alc": "9335.51",
"icms-20-alc": "9452.21",
"icms-21-alc": "9571.86",
"icms-22-alc": "9694.57",
"icms-23-alc": "9820.47",
"withoutTaxes": "7561.77",
"icms-17.5-alc": "9165.78",
"icms-19.5-alc": "9393.50",
"icms-20.5-alc": "9511.65",
"icms-22.5-alc": "9757.11"
},
"pisCofinsList": "Negativa",
"substanceText": "MEPOLIZUMABE",
"targetSpecies": [],
"consumerPrices": {
"icms-0": "11361.10",
"icms-12": "12910.35",
"icms-17": "13688.07",
"icms-18": "13855.01",
"icms-19": "14026.06",
"icms-20": "14201.39",
"icms-21": "14381.14",
"icms-22": "14565.51",
"icms-23": "14754.67",
"icms-17.5": "13771.03",
"icms-19.5": "14113.17",
"icms-20.5": "14290.70",
"icms-22.5": "14659.50",
"icms-12-alc": "11879.21",
"icms-17-alc": "12594.81",
"icms-18-alc": "12748.42",
"icms-19-alc": "12905.79",
"icms-20-alc": "13067.13",
"icms-21-alc": "13232.53",
"icms-22-alc": "13402.17",
"icms-23-alc": "13576.22",
"withoutTaxes": "10453.70",
"icms-17.5-alc": "12671.15",
"icms-19.5-alc": "12985.96",
"icms-20.5-alc": "13149.30",
"icms-22.5-alc": "13488.63"
},
"invalidBarcodes": [],
"activeSubstances": [
"MEPOLIZUMABE"
],
"therapeuticClass": "R3M - ANTIASMÁTICOS INIBIDORES DA INTERLEUCINA",
"commercialisation": {
"year": 2025,
"marketed": true
},
"priceAnalysisNote": null,
"useDomainEvidence": {
"basis": "unreviewed",
"field": null,
"value": null,
"version": 1,
"sourceId": "br.anvisa.cmed-prices"
},
"patientEligibility": "not-assessed",
"registrationNumber": "1010703350032",
"targetSpeciesStatus": "not-reported",
"administrativeStatus": "unknown",
"prescriptionCategory": "prescription-or-restricted",
"prescriptionRequired": true,
"therapeuticClassCode": "R3M",
"commercialDestination": null,
"registrationNumberFlag": null
}
Leia este registro a partir do seu próprio software
O mesmo registro, com todos os campos e sua procedência, está a uma requisição de distância. A chave de API é gratuita e funciona imediatamente.
curl -G "https://api.medifontis.com/v1/drugs/record" \
-H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
--data-urlencode "country=br" \
--data-urlencode "sourceId=br.anvisa.cmed-prices" \
--data-urlencode "id=br:cmed:presentations:510620110056207"